Keyphrases
Adaptation
9%
Ampicillin
21%
Antibiotics
28%
Antimicrobial
16%
Antimicrobial Peptides
12%
Antimicrobial Resistance
11%
Bacteremia
16%
Bloodstream Infection
19%
Carbapenem-resistant Enterobacterales
10%
Carbapenemase-producing
9%
Cefazolin
13%
Cefazolin Inoculum Effect
21%
Cell Membrane
16%
Colombia
14%
Colombians
9%
Daptomycin
100%
Daptomycin Resistance
30%
E. Faecalis
23%
Endocarditis
14%
Enterococcal Infections
11%
Enterococcus
40%
Enterococcus Faecalis
51%
Enterococcus Faecium
57%
High Inoculum
10%
Infective Endocarditis
15%
Klebsiella Pneumoniae (K. pneumoniae)
13%
Klebsiella Pneumoniae Carbapenemase
12%
Lactams
14%
Latin America (LATAM)
12%
LiaFSR
21%
Liar
14%
Linezolid
15%
Linezolid Resistant Enterococci
17%
Methicillin-resistant Staphylococcus Aureus
57%
Minimum Inhibitory Concentration
11%
Multicenter Cohort Study
10%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
14%
Plasmid
10%
Pseudomonas Aeruginosa (P. aeruginosa)
12%
Resistance Mechanisms
10%
Sequence Type
13%
Staphylococcus Aureus
22%
Susceptibility Testing
9%
United States
14%
Vancomycin
27%
Vancomycin Resistance
25%
Vancomycin-resistant Enterococci
36%
Virulence
12%
Whole Genome Sequencing
16%
β-lactamase
15%
Immunology and Microbiology
Antibiotic Resistance
25%
Antibiotic Sensitivity
12%
Antimicrobial Peptides
16%
Bacteriophage
7%
Biofilm
5%
Broth Dilution
9%
Candida Auris
5%
Cell Membrane
20%
Cell Wall
6%
Cladistics
5%
Cohort Effect
11%
Colony Forming Unit S
8%
Colony-Forming Unit
9%
Drug Megadose
7%
Endocarditis
22%
Enterobacterales
13%
Enterococcus
35%
Enterococcus faecalis
49%
Enterococcus faecium
46%
Enterococcus gallinarum
5%
Escherichia coli
11%
Etest
7%
Glycopeptide
6%
In Vitro
21%
Infection
84%
Infectious Agent
20%
Inoculum
28%
Klebsiella pneumoniae
16%
Lineage
16%
Methicillin Susceptible Staphylococcus Aureus
24%
Methicillin-Resistant Staphylococcus Aureus
37%
Minimum Inhibitory Concentration
40%
Molecular Epidemiology
9%
Penicillin Binding Protein
8%
Peptidoglycan
7%
Peritonitis
6%
Pharmacodynamics
5%
Phylogenomics
6%
Plasmid
15%
Prevalence
12%
Pseudomonas aeruginosa
16%
Ribosome RNA
5%
Staphylococcus aureus
26%
Stenotrophomonas maltophilia
5%
Streptococcus Mitis
7%
Susceptibility
31%
Vancomycin Resistance
11%
Vancomycin-Resistant Enterococcus
26%
Whole Genome Sequencing
22%
Wild Type
7%